Need To Reform Spanish Health Care, Says Health Secretary

3 March 1997

Spanish health care needs to be reformed now to keep this in line withthe expected domestic economic growth, at least on a two-yearly basis, and also to curb the increasing social security deficit, according to Spain's Secretary of State for Social Security, Juan Carlo Aparicio. The health care system currently absorbs 5% of Spain's Gross Domestic Product and is taking a larger share of public funds, he added.

However, Mr Aparicio noted that reform is complicated by the fact that regional governments, which now offer medical services to about 60% of all Spaniards, have to be involved in any reform. A stability pact to keep regional spending under control is expected this year.

Health care reform should go in the same direction as the pension reform already accomplished, he said, but warned that health care will be more difficult. The three guidelines for reform are keeping expenditure growth in line with economic growth, using both private and public resources, and improving efficiency in administration, he said, noting that agreement is desirable and possible but very complex. Mr Aparicio did not give any indication about the timing of health care reforms.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight